The Food and Drug Administration is again trying to rehire some staffers who were recently fired amid mass layoffs at the ...

In an exclusive interview with physician and writer Dr. Jeremy Faust on Substack, Makary opened up about his first weeks on ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Encompass Health tapped Patrick Tuer to serve as its first COO. He has held various leadership positions, including group ...

The U.S. Transportation Department said Thursday it is taking steps to retain and recruit more air traffic controllers to ...

Biogen beat first-quarter profit and revenue expectations on Thursday, as strong demand for its rare disease drugs helped ...

Gilead will pay $202 million to resolve claims that it paid kickbacks to healthcare providers in the form of honoraria, meals ...

A recall of seafood burgers by the Connecticut based company Caraluzzi's Markets has been issued a Class I risk ...

Several current and former FDA employees who spoke to Inside Medicine on the condition of anonymity have come to see the ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The US Food and Drug Administration has approved nipocalimab-aahu, a new FcRn- blocking monoclonal antibody, for the ...

The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening ...